A5013457703- Rheumatoid Arthritis Research and Therapies
- Lung Cancer Treatments and Mutations
- Biosimilars and Bioanalytical Methods
- Dietary Effects on Health
- Lung Cancer Research Studies
- Body Contouring and Surgery
- Heme Oxygenase-1 and Carbon Monoxide
- Diet and metabolism studies
- Olfactory and Sensory Function Studies
- Viral Infections and Immunology Research
- Chronic Disease Management Strategies
- Medical research and treatments
- Adrenal Hormones and Disorders
- Pleural and Pulmonary Diseases
- Brain Metastases and Treatment
- Porphyrin Metabolism and Disorders
- Science, Research, and Medicine
- Traumatic Brain Injury and Neurovascular Disturbances
- Acute Kidney Injury Research
- Chemical Reactions and Isotopes
- Immunodeficiency and Autoimmune Disorders
- Contact Dermatitis and Allergies
- Cancer, Stress, Anesthesia, and Immune Response
- Pharmaceutical studies and practices
- Congenital Diaphragmatic Hernia Studies
Fundacion Instituto de Reumatologia Fernando Chalem
2019-2024
Center for Rheumatology
2018
Vrije Universiteit Amsterdam
1962-1979
University of Amsterdam
1941-1975
<h3>Background:</h3> Rheumatoid arthritis (RA) is a chronic, autoimmune disease that requires targeted therapy focused on multidisciplinary approach in which several specialties intervene to improve the illness outcome. <h3>Objectives:</h3> The aim of present study describe and analyze impact care model (Rheumatologist, rehabilitation physical medicine, nutritionist, psychology medical doctor) activity long-standing RA cohort. <h3>Methods:</h3> A retrospective observational was started...
<h3>Background:</h3> Rheumatic diseases are known as disorders that mainly affect the components of musculoskeletal system: tendons, ligaments, bones, joints and muscles. The off-label use medications may be justified in cases where a therapeutic option or alternative is required some population groups. One with greatest Rituximab (RTX), which described literature. In Latin America, unauthorized uses have little description literature, so this work aims to reveal impact on prescription...
<h3>Background:</h3> Rheumatoid arthritis (RA) is a common chronic inflammatory disease. It characterized by progressive, joint damage, impaired function and pain, the disease causes disability reduces quality of life. Treat-to-target (T2T) an acknowledged management strategy for RA; it proposes that therapeutic target in RA should be state remission or low activity. There are two types pharmacological therapy available: biological DMARDs considered highly expensive our countries...
<h3>Background</h3> Rheumatoid arthritis (RA) is an inflammatory autoimmune disease with a prevalence of 0.5 to 1% and the advances in pharmacological treatments offered manage have achieved many goals; however, appearance biologics has made treatment RA very costly, which great impact developing countries where accessibility these therapies lower. On other hand, we now know that patients who are clinical remission activity by clinimetry significant percentage cases may so-called subclinical...
<h3>Background:</h3> Treat to target (T2T) strategy for rheumatoid arthritis (RA) aims achieve remission or low disease activity. On the other hand, biological disease-modifying antirheumatic drugs (bDMARDs) have shown be effective clinical or, at least, activity in patients with RA. comprehensive healthcare programs demonstrated good outcomes chronic conditions. <h3>Objectives:</h3> The aim of this study was describe global change Disease Activity Score 28 (DAS28) receiving therapy during 5...
<h3>Background:</h3> Rheumatoid arthritis (RA) is a common chronic inflammatory disease. Treat-to-target (T2T) management strategy for R that proposes as the therapeutic target state of remission or low disease activity, additionally multidisciplinary patients with RA has demonstrate to be an additional aid achieve activity. Real-world evidence (RWE) refers information coming from electronic health records, billing data, registries among others. RWE shows results are difficult clinical...
Introducción: La hiperosmolaridad de las secreciones por altas concentraciones iones se ha correlacionado con la hiperreactividad bronquial, esto llevó a considerar el uso furosemida inhalada como tratamiento adicional en asma bronquial. Objetivo: Evaluar si administración nebulizada asociado al convencional del severo pacientes mayores 5 años disminuye tiempo crisis y permanencia Departamento Emergencia (DE). Metodología: Estudio randomizado controlado exacerbación asmática severa un DE. Se...